QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Minimolide F | Minimolide F | 1367351-41-4 |
| dinutuximab | dinutuximab | 1363687-32-4 |
| PLYZLMIGSHCAEW-UHFFFAOYSA-N | PLYZLMIGSHCAEW-UHFFFAOYSA-N | 1345826-33-6 |
| Cy5-alkyne | Cy5-炔烃 | 1223357-57-0 |
| dupilumab | 度匹鲁单抗 | 1190264-60-8 |
| sarilumab | SARILUMAB | 1189541-98-7 |
| Ozoralizumab | Ozoralizumab | 1167985-17-2 |
| Alirocumab | 阿利库单抗 | 1245916-14-6 |
| Ixekizumab | 伊西贝单抗 | 1143503-69-8 |
| Samalizumab | Samalizumab | 1073059-33-2 |
| Benralizumab | BENRALIZUMAB | 1044511-01-4 |
| Etrolizumab | ETROLIZUMAB ( 依曲利组单抗 ) | 1044758-60-2 |
| N-BIOTINYLCAPROYLAMINOCAPROYLAMINOETHYL METHANETHIOSULFONATE | N-[6-(2-甲基磺酰基硫基乙基氨基)-6-氧代己基]-6-[5-[(4S)-2-氧代-1,3,3A,4,6,6A-六氢噻吩并[3,4-D]咪唑-4-基]戊酰氨基]己酰胺 | 1038749-81-3 |
| Pidilizumab | Pidilizumab | 1036730-42-3 |
| Trastuzumab emtansine | 曲妥珠单抗-美坦新偶联物 | 1018448-65-1 |
| IMMunoglobulin G2 | 吉伏组单抗 | 1129435-60-4 |
| FMS | FMS | 197777-71-2 |
| Rovelizumab [usan:inn] | ROVELIZUMAB | 197099-66-4 |
| mepolizumab | 美泊利单抗 | 196078-29-2 |
| 6-CARBOXY-X-RHODAMINE | 6-羧基-X-罗丹明 | 194785-18-7 |
